Relay Therapeutics, Inc. (RLAY)
8.70
-0.16
(-1.81%)
USD |
NASDAQ |
Feb 20, 16:00
8.61
-0.09
(-1.03%)
After-Hours: 20:00
Relay Therapeutics SG&A Expense (Quarterly) : 12.13M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Eli Lilly & Co. | 3.132B |
| Celcuity, Inc. | 7.934M |
| Prelude Therapeutics, Inc. | 5.21M |
| Immunome, Inc. | 10.94M |
| ImmunityBio, Inc. | 36.28M |